These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 29667436)
21. Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases. Oprita R; Bratu M; Oprita B; Diaconescu B J Med Life; 2016; 9(2):160-2. PubMed ID: 27453747 [TBL] [Abstract][Full Text] [Related]
22. Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients. Bruno G; Gagliardi A; Oliva A; Trancassini M; Macone A; Cicerone C; D'Abramo A; Iebba V; Auria S; Bonfiglio G; Zingaropoli MA; D'Ettorre G; Badiali D; Vullo V; Corazziari ES; Schippa S New Microbiol; 2019 Oct; 42(4):221-224. PubMed ID: 31609455 [TBL] [Abstract][Full Text] [Related]
23. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956 [TBL] [Abstract][Full Text] [Related]
24. The role of gut microbiota in Clostridium difficile infection. Samarkos M; Mastrogianni E; Kampouropoulou O Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498 [TBL] [Abstract][Full Text] [Related]
25. Decreased Complexity of Serum N-glycan Structures Associates with Successful Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Monaghan TM; Pučić-Baković M; Vučković F; Lee C; Kao D; Gastroenterology; 2019 Dec; 157(6):1676-1678.e3. PubMed ID: 31476300 [No Abstract] [Full Text] [Related]
26. [Fecal microbiota transplantation: indications and perspectives]. Lagier JC; Raoult D Med Sci (Paris); 2016 Nov; 32(11):991-997. PubMed ID: 28008840 [TBL] [Abstract][Full Text] [Related]
27. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119 [TBL] [Abstract][Full Text] [Related]
28. A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma. Trubiano JA; George A; Barnett J; Siwan M; Heriot A; Prince HM; Slavin MA; Teh BW Leuk Lymphoma; 2015 Feb; 56(2):512-4. PubMed ID: 24828871 [No Abstract] [Full Text] [Related]
29. [Case series of Clostridium difficile NAP1/027/BI with novels treatments]. Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949 [TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review. Iqbal U; Anwar H; Karim MA Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):730-734. PubMed ID: 29688901 [TBL] [Abstract][Full Text] [Related]
31. Exploring ways to improve CDI outcomes. Galpérine T; Guery B; Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930 [TBL] [Abstract][Full Text] [Related]
32. Fecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications. Shaukat A; Reinink AR Am Fam Physician; 2017 Mar; 95(6):351-352. PubMed ID: 28318210 [No Abstract] [Full Text] [Related]